Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Atherosclerosis. 2010 Apr 14;211(1):122–129. doi: 10.1016/j.atherosclerosis.2010.04.005

Figure 5. RUNX2 expression and transcriptional activity are increased in LPC-treated VSMCs.

Figure 5

(A) Real-time PCR, RUNX2, 14d, n=3-7, # p<0.05. (B) RUNX2-Luciferase Reporter Assay; 14d, n=3, *p<0.001. RLU, relative luciferase units. (C) Temporal Luciferase Assay, 10d-14d, n=3, *p<0.01, # p<0.05. Error bars represent ±SD. (D) Schnurri 3 (protein) ELISA; n=3 *p<0.05. Schnurri 3 protein (μg) normalized to total protein (μg).